… treatment of multiple myeloma: a randomized controlled trial. … with bortezomib alone in
relapsed or refractory multiple myeloma: … in previously untreated patients with multiple myeloma: a …

… for randomised clinical trials was conducted using the following electronic databases and
clinical trial … Through these mechanisms, the use of bortezomib has been associated with …

… elderly patients with multiple myeloma: randomised controlled trial. … Bortezomib induction
and maintenance treatment in patients … diagnosed multiple myeloma: results of the randomized …

… Items for Systematic Reviews and Meta-analysis (PRISMA) … bortezomib versus placebo
plus bortezomib 286 Siltuximab plus bortezomib : 64 (range : 36- 82) ; placebo plus bortezomib : …

… (NMA) of efficacy and toxicity data from all existing randomized controlled trials (RCT) …
study population comprised of previously untreated patients with symptomatic Multiple Myeloma …

… We did a systematic review of randomised controlled trials that reported SPM in patients …
used fixed effects for stratified meta-analysis of multiple myeloma studies. Risk of bias was …

… studies that have assessed HRQOL in MM patients have mainly focused on newly diagnosed
patients enrolled in randomized controlled trials (… the APEX trial, patients in the bortezomib …

… We therefore conducted a systematic review and meta-analysis to assess the possible …
infection in patients with multiple myeloma (MM). We searched randomized controlled trials (RCTs…

… 3, randomized controlled trial (RCT)—found no significant difference in progression-free
survival (PFS) between previously-untreated patients … (KRd) versus bortezomib/lenalidomide/…

… or institutional review boards of all participating institutions, and all patients provided written
informed consent. All authors had access to the primary clinical trial data. Randomization …